Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2439-2025Class II

TherMax Blood Warmer Unit-US, PrisMax Accessory, Product Codes: 955630, 955515, 955702, 955631

Baxter Healthcare Corporation / initiated 2025-07-28 / Open, Classified

VANTIVE US HEALTHCARE LLC began a recall of TherMax Blood Warmer Unit-US, PrisMax Accessory, Product Codes: 955630, 955515, 955702, 955631 on . FDA classified it as Class II and gives the reason as "Thermax System may be unable to detect the presence of a bag on the Thermax Blood Warmer Unit leading to difficulty setting up therapy, or PrisMax System alarm T2284: Thermax Disposable Not Inserted". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-2439-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Baxter Healthcare Corporation
Product
TherMax Blood Warmer Unit-US, PrisMax Accessory, Product Codes: 955630, 955515, 955702, 955631
Product code
KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System
Reason for recall
Thermax System may be unable to detect the presence of a bag on the Thermax Blood Warmer Unit leading to difficulty setting up therapy, or PrisMax System alarm T2284: Thermax Disposable Not Inserted
FDA root cause
Under Investigation by firm
Action
Vantive issued an Urgent Medical Device Correction notice to it consignees on 0728/2025 via USPS first class mail. The notice explained the issues with the devices, hazard involved, and requested the following: Actions to be Taken by Customers 1. Operators may continue to safely use the PrisMax Systems and TherMax Blood Warmer Units per the associated Operator s Manuals and on-screen instructions. If further assistance is required, please contact your local Vantive account representative. Please ensure that all operators of these devices are made aware of this Urgent Medical Device Correction notification. Vantive recommends that a copy of this notification is posted within the appropriate location of your facility. 2. As corrections become available, a local Vantive representative will contact your facility to determine the correction plan and schedule the associated correction(s) for impacted devices. 3. If you received this communication directly from Vantive, complete the enclosed Vantive Customer Reply Form and return it to Vantive by scanning and e-mailing it to [email protected]. Returning the customer reply form promptly will confirm your receipt of this notification and prevent you from receiving repeat notices. If you do not return the customer reply form, you will receive an email and/or phone call from Vantive to confirm your receipt of this notification. 4. If you purchased this product from a distributor, please note that responding using the Vantive Customer Reply Form is not applicable. If a response is requested by your distributor or wholesaler, please respond to the supplier according to their instructions. 5. If you distributed this product to other facilities or departments within your institution, please forward a copy of this communication to them. 6. If you are a dealer, wholesaler, distributor/reseller, or original equipment manufacturer (OEM) that distributed any affected product to other facilities, please notify your
Quantity in commerce
7432 units
Distribution
Worldwide
Product codes and lots
UDI 07332414124731, All serial numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2439-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2437-2025Class IIOngoingVoluntary: Firm initiated
Z-2438-2025Class IIOngoingVoluntary: Firm initiated
Z-2439-2025Class IIOngoingVoluntary: Firm initiated